Their own payment-practices filing · gov.uk
Pharm Research Associates (UK) Limited pays suppliers in 30 days on average — inside its 60-day stated terms
Their H2 2025 filing puts the average 30 days inside their stated 60-day term.
- Their stated terms
- 60 days
- Paid outside agreed terms
- 18% of invoices
- Paid after 61+ days
- 9%
- Reporting period
- 1 Jul 2025 – 31 Dec 2025
- Source
- their gov.uk filing, filed 11 Mar 2026
Self-reported figures from their statutory filing. How this is compiled.
Terms vs reality · their H2 2025 filing
Paid 30 days inside the 60-day term they state
Where their invoices landed · share of all invoices
The pattern · last 6 of 16 reports
82 → 30 days — getting faster
The read · computed from their figures
Pharm Research Associates (UK) Limited's H2 2025 filing puts their average at 30 days against stated terms of 60 days; 18% of invoices were paid outside agreed terms and 9% took 61 days or longer. Filed 11 Mar 2026.
The direction is faster: from 82 days in H1 2023 to 30 now — 52 days faster across their last 6 reports.
On the latest reported averages: Slower than 54% of the 476 large companies reporting in information & communication.
That is 16 statutory periods on record (earliest H1 2018) — a historical record, not a promise for a new invoice.
In their own words · from the filing
Standard payment terms
In general, the company has 30 day standard payment terms for suppliers, unless agreed separately by both parties.
Dispute resolution
The company will endeavor to advise suppliers promptly of any disputes or reasons why an invoice will not be paid to the agreed terms. Invoices that are subject to dispute will not be paid until resolution of the dispute. Once resolved, payment will be made in accordance with the terms of this policy.
Every statutory report on record
Most recent first.
| Period | Avg days | Outside terms | 61+ days | Filed |
|---|---|---|---|---|
| H2 2025 | 30 | 18% | 9% | 11 Mar 2026 |
| H1 2025 | 87 | 38% | 26% | 17 Aug 2025 |
| H2 2024 | 71 | 39% | 26% | 28 Jan 2025 |
| H1 2024 | 82 | 37% | 27% | 18 Jul 2024 |
| H2 2023 | 83 | 43% | 32% | 30 Jan 2024 |
| H1 2023 | 82 | 50% | 38% | 28 Jul 2023 |
| H2 2022 | 67 | 47% | 31% | 31 Jan 2023 |
| H1 2022 | 36 | 30% | 13% | 21 Jul 2022 |
| H2 2021 | 36 | 29% | 11% | 27 Jan 2022 |
| H1 2021 | 35 | 28% | 11% | 27 Jul 2021 |
| H2 2020 | 34 | 25% | 9% | 26 Jan 2021 |
| H1 2020 | 34 | 25% | 9% | 22 Jul 2020 |
| H2 2019 | 34 | 23% | 8% | 30 Jan 2020 |
| H1 2019 | 36 | 29% | 10% | 31 Jul 2019 |
| H2 2018 | 50 | 39% | 15% | 30 Jan 2019 |
| H1 2018 | 33 | 29% | 7% | 27 Jul 2018 |
On the public register · Companies House
Company record
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 9 Sept 1996
- Registered office
- 3RD FLOOR NORTH & SOUTH WINGS 100 LONGWATER AVENUE, READING, RG2 6GP
Quick answers · Pharm Research Associates (UK) Limited
Are they getting slower or faster?
What's their typical pay point?
Can I see what this means for my invoices?
Stay ahead
Watch Pharm Research Associates (UK) Limited (free)
We watch their public record and email you when something changes — a new payment report, late filings, insolvency markers, new charges.
You’ll get a confirmation email first. Unsubscribe any time. How we handle your address.
More large companies in information & communication
PGDS (UK One) Limited · Pharma Intelligence U.K. Limited · Penguin Books Limited · Phonographic Performance Limited · Pegasystems Limited · Photobox Limited
How UK payment reporting works
What is a Payment Practices Report?
What does "paid outside agreed terms" mean?
How often is this data updated?
Is this official government data?
How this is compiled. Built from official records only: Companies House and the gov.uk payment-practices service. The payment figures are self-reported — companies over the size threshold must file them by law and the board signs them off. No credit-agency data. The numbers are theirs; the plain-English read is ours. This is information compiled from public records under the Open Government Licence v3.0 — not a credit rating and not advice.
The 31-day comparison figure is the median across 6,104 companies with a current statutory report — every sector pooled, not an average of sector medians (how the figure is built).
Report PL-03247443 · latest period to 31 Dec 2025
Built by YORXEN LTD · registered in England & Wales · CRN 17303256 · privacy · terms.